Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn's disease: a 24-week multicenter study from China.
- DOI
- 10.5217/ir.2026.00114
- Published
- 2026 Sep 4
- Container
- Intestinal research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5217/ir.2026.00114,
title = {Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn's disease: a 24-week multicenter study from China.},
author = {Zhang Z and Zhang S and Ge W and Li Y and Chen R and Tang W and Wang Q and Fan Y and Zhou L and Tian F and Chen C and Gu Y and Zou D},
year = {2026},
journal = {Intestinal research},
doi = {10.5217/ir.2026.00114},
url = {https://doi.org/10.5217/ir.2026.00114}
}RIS
TY - JOUR TI - Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn's disease: a 24-week multicenter study from China. AU - Zhang Z AU - Zhang S AU - Ge W AU - Li Y AU - Chen R AU - Tang W AU - Wang Q AU - Fan Y AU - Zhou L AU - Tian F AU - Chen C AU - Gu Y AU - Zou D PY - 2026 JO - Intestinal research DO - 10.5217/ir.2026.00114 UR - https://doi.org/10.5217/ir.2026.00114 ER -
APA
Z, Z., S, Z., W, G., Y, L., R, C., W, T., Q, W., Y, F., L, Z., F, T., C, C., Y, G., & D, Z. (2026). Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn's disease: a 24-week multicenter study from China.. Intestinal research. https://doi.org/10.5217/ir.2026.00114
Source records
- pubmed · retrieved 2026-09-25T20:52:01.473Z